Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Inventory | -13.91%233.28M | -28.06%226.85M | -13.31%270.98M | 12.32%315.32M | 49.11%312.58M | -12.80%280.73M | -28.10%209.63M | 26.16%321.94M | -24.54%291.54M | -29.19%255.19M |
| Accounts receivable | 31.58%91.97M | 10.88%67.93M | 5.52%69.9M | 9.32%61.26M | -13.97%66.24M | -23.83%56.04M | 8.31%77M | 11.05%73.57M | 101.48%71.09M | 87.12%66.25M |
| Advance deposits and other receivables | 5.01%162.83M | -19.26%130M | 7.04%155.05M | 18.34%161.02M | 13.55%144.86M | -21.29%136.07M | -39.26%127.57M | -1.48%172.86M | 32.81%210.04M | 11.14%175.46M |
| Cash and equivalents | -34.87%877.52M | 16.72%1.25B | 15.46%1.35B | -13.76%1.07B | 2.10%1.17B | -40.74%1.25B | -52.69%1.14B | 32.74%2.1B | 102.06%2.42B | 27.97%1.58B |
| Secured deposit | ---- | ---- | ---- | -96.00%4M | ---- | --100M | 56.25%100M | ---- | -80.96%64M | 82.87%384.07M |
| Financial assets at fair value-current assets | --92.06M | --113.03M | ---- | ---- | -81.05%276.64M | 8.20%717.19M | 103.56%1.46B | -58.78%662.81M | --717.08M | --1.61B |
| Derivative financial instruments-current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --19.42M |
| Special items of current assets | 16.42%120.21M | -80.43%100.73M | -86.14%103.26M | 67.37%514.75M | 33.66%744.9M | -32.33%307.55M | 51.82%557.32M | 95.73%454.5M | -48.65%367.1M | -69.48%232.2M |
| Total current assets | -18.94%1.58B | -11.18%1.89B | -28.23%1.95B | -25.06%2.13B | -26.18%2.71B | -24.93%2.84B | -11.18%3.67B | -12.40%3.79B | 46.36%4.14B | 56.55%4.32B |
| Non-current assets | ||||||||||
| Property, plant and equipment | -7.38%1.27B | -5.22%1.32B | -3.51%1.37B | -3.81%1.39B | -2.32%1.42B | 0.56%1.45B | 2.32%1.46B | 2.17%1.44B | 0.38%1.42B | -0.12%1.41B |
| Investment property | --10.08M | --10.25M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Advance payment | 260.12%428.53M | 140.94%277.12M | 11.01%119M | -6.68%115.02M | -19.30%107.19M | -6.71%123.24M | 21.87%132.83M | 24.89%132.11M | 0.30%108.99M | -1.41%105.78M |
| Associated company interest | 2.33%612.24M | -0.58%627.85M | -5.78%598.27M | -0.28%631.5M | 9.55%634.97M | 11.24%633.25M | 83.51%579.63M | 105.46%569.27M | 29.30%315.86M | 10.64%277.07M |
| Financial assets at fair value-non-current assets | ---- | ---- | 37.31%164.77M | 0.00%120M | 0.00%120M | 0.00%120M | 0.00%120M | 0.00%120M | --120M | --120M |
| Intangible assets | -4.19%11.99M | -0.44%13.21M | -19.66%12.52M | -30.30%13.27M | -36.17%15.58M | -24.71%19.03M | -6.71%24.41M | -17.70%25.28M | -17.90%26.17M | -13.35%30.72M |
| Deferred tax assets | 4.49%117.9M | 21.03%125.52M | 16.02%112.84M | -1.32%103.71M | 12.51%97.26M | 24.91%105.11M | 13.14%86.45M | 4.04%84.15M | -18.50%76.41M | 14.81%80.88M |
| Total non-current assets | 0.04%2.75B | -2.44%2.7B | -1.58%2.75B | -4.35%2.76B | -3.68%2.79B | 1.34%2.89B | 9.45%2.9B | 10.01%2.85B | 3.65%2.65B | -4.64%2.59B |
| Total assets | -7.83%4.33B | -6.24%4.59B | -14.71%4.7B | -14.63%4.89B | -16.26%5.51B | -13.65%5.73B | -3.12%6.57B | -4.00%6.64B | 26.08%6.79B | 26.21%6.91B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Accounts payable | -6.65%85.85M | -40.81%57.06M | 34.89%91.97M | -10.28%96.4M | -8.95%68.18M | 37.87%107.44M | -21.48%74.88M | -9.79%77.93M | 45.05%95.37M | -29.18%86.39M |
| Tax payable | -26.18%29.71M | -20.76%32.66M | 15.06%40.25M | 24.83%41.21M | 147.12%34.98M | -28.76%33.02M | -78.59%14.15M | 21.96%46.35M | 185.79%66.12M | -40.84%38M |
| Other payables and accrued expenses | 2.45%355.4M | 4.05%391.33M | -7.19%346.89M | -4.89%376.1M | -2.31%373.78M | -15.22%395.43M | -18.28%382.63M | 1.54%466.43M | 23.11%468.23M | 38.48%459.35M |
| Bank loans and overdrafts | -43.74%84.4M | --150M | 7.14%150M | ---- | -54.84%140M | 220.00%160M | 181.82%310M | -87.52%50M | -67.59%110M | --400.77M |
| Derivative financial instrument-current liabilities | ---- | ---- | ---- | ---- | -92.19%3.29M | -50.82%16.86M | -47.15%42.14M | -31.70%34.28M | --79.74M | --50.18M |
| Financial lease liabilities-current liabilities | -23.96%132.07M | -21.26%132.43M | -16.49%173.68M | -15.72%168.18M | 4.02%207.98M | 5.27%199.54M | -1.55%199.95M | -15.54%189.55M | -34.55%203.09M | 2.25%224.41M |
| Special items of current liabilities | 46.08%3.34M | 0.00%2.28M | 0.00%2.28M | 0.00%2.28M | -6.13%2.28M | -3.75%2.28M | 2.53%2.43M | 0.00%2.37M | 12.95%2.37M | 62.02%2.37M |
| Total current liabilities | -14.20%690.76M | 11.92%765.75M | -3.06%805.06M | -25.19%684.18M | -19.07%830.49M | 5.50%914.57M | 0.12%1.03B | -31.28%866.91M | -8.57%1.02B | 70.73%1.26B |
| Net current assets | -22.28%887.11M | -22.10%1.13B | -39.34%1.14B | -25.00%1.45B | -28.94%1.88B | -33.97%1.93B | -14.90%2.65B | -4.62%2.92B | 82.46%3.11B | 51.37%3.06B |
| Total assets less current liabilities | -6.51%3.64B | -9.20%3.82B | -16.78%3.89B | -12.62%4.21B | -15.74%4.68B | -16.53%4.82B | -3.70%5.55B | 2.08%5.77B | 35.19%5.76B | 19.27%5.65B |
| Non-current liabilities | ||||||||||
| Financial lease liabilities-non-current liabilities | -28.19%57.42M | -28.67%81.77M | -5.51%79.96M | -23.93%114.64M | -54.87%84.62M | -18.38%150.7M | -10.05%187.5M | -8.27%184.65M | 0.18%208.45M | -53.89%201.31M |
| Deferred tax liability | 14.37%62.34M | -31.24%63.38M | -4.37%54.51M | 64.19%92.17M | -15.36%57M | 1.31%56.13M | 31.57%67.34M | 36.60%55.41M | 196.56%51.19M | 136.21%40.56M |
| Convertible notes and bonds | ---- | ---- | ---- | ---- | -80.37%230.58M | -64.35%439.68M | -5.26%1.17B | -0.55%1.23B | --1.24B | --1.24B |
| Special items of non-current liabilities | -11.08%50.93M | -24.64%50.39M | -22.48%57.28M | -18.78%66.86M | -15.75%73.9M | -5.81%82.32M | 4.94%87.71M | 23.91%87.4M | 80.78%83.58M | 47.21%70.54M |
| Total non-current liabilities | -10.98%170.69M | -28.55%195.54M | -57.02%191.75M | -62.45%273.67M | -70.60%446.09M | -53.30%728.84M | -4.16%1.52B | 0.53%1.56B | 482.96%1.58B | 209.50%1.55B |
| Total liabilities | -13.58%861.45M | 0.36%961.29M | -21.92%996.81M | -41.72%957.85M | -49.81%1.28B | -32.31%1.64B | -2.48%2.54B | -13.73%2.43B | 87.29%2.61B | 126.85%2.81B |
| Total assets less total liabilities | -6.28%3.47B | -7.85%3.63B | -12.53%3.7B | -3.74%3.94B | 4.92%4.23B | -2.90%4.09B | -3.53%4.03B | 2.67%4.21B | 4.72%4.18B | -3.25%4.1B |
| Total equity and non-current liabilities | -6.51%3.64B | -9.20%3.82B | -16.78%3.89B | -12.62%4.21B | -15.74%4.68B | -16.53%4.82B | -3.70%5.55B | 2.08%5.77B | 35.19%5.76B | 19.27%5.65B |
| Equity | ||||||||||
| Share capital | -6.67%14K | -6.25%15K | -6.25%15K | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K |
| Reserve | -4.47%3.92B | -4.68%4.09B | -9.33%4.11B | -2.88%4.29B | 3.96%4.53B | -3.05%4.41B | -1.90%4.36B | 4.29%4.55B | 4.37%4.44B | -3.06%4.36B |
| Shareholders' Equity | -6.28%3.47B | -7.85%3.63B | -12.53%3.7B | -3.74%3.94B | 4.92%4.23B | -2.90%4.09B | -3.53%4.03B | 2.67%4.21B | 4.72%4.18B | -3.25%4.1B |
| Total equity | -6.28%3.47B | -7.85%3.63B | -12.53%3.7B | -3.74%3.94B | 4.92%4.23B | -2.90%4.09B | -3.53%4.03B | 2.67%4.21B | 4.72%4.18B | -3.25%4.1B |
| Total equity and total liabilities | -7.83%4.33B | -6.24%4.59B | -14.71%4.7B | -14.63%4.89B | -16.26%5.51B | -13.65%5.73B | -3.12%6.57B | -4.00%6.64B | 26.08%6.79B | 26.21%6.91B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young Accounting Firm | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young Accounting Firm | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.